Fatigue News and Research

RSS

FDA approval of Tysabri, for the treatment of multiple sclerosis

Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.

24 Nov 2004

Highly obese women are 12 times more likely to have diabetes

Highly obese women are 12 times more likely to have diabetes or knee replacement surgery, and five times more likely to have high blood pressure than women who are at a normal weight, says a new study.

23 Nov 2004

Study provides the first detailed description of errors by hospital staff nurses

A University of Pennsylvania School of Nursing study provides the first detailed description of the nature and prevalence of errors by hospital staff nurses.

20 Nov 2004

New study has found that, even with prolonged sobriety, alcoholics will have difficulties completing tasks such as putting pieces of a puzzle together or map reading

A new study has found that, even with prolonged sobriety, alcoholics show deficits in visuoperception and frontal executive functioning of the brain. Furthermore, alcoholics utilize a more complex higher-order cognitive system, frontal executive functions, to perform the same tasks as individuals without a history of alcoholism. Results are published in the November issue of Alcoholism: Clinical & Experimental Research.

14 Nov 2004

New valve repair device that could replace major heart surgery

The Hospital of the University of Pennsylvania (HUP) is participating in a nationwide clinical trial of a new valve repair device that could replace major heart surgery in some patients.

8 Nov 2004

European approval for Taxotere (docetaxel) in prostate cancer

Aventis, part of the sanofi-aventis Group announced today that the European Commission has approved Taxotere (docetaxel) Injection Concentrate for use in combination with prednisone as a treatment for men with androgen-independent (hormone- refractory) metastatic prostate cancer.

4 Nov 2004

Health professionals fall short for Hepatitis C patients

People living with Hepatitis C are highly critical of the treatment they have received from health professionals, particularly doctors, according to a new study by a University of Auckland sociology researcher.

3 Nov 2004

Pegasys with ribavirin combo may best for reducing hepatitis C viral levels

Interim study results indicate a certain drug combination treatment may suppress the hepatitis C virus more quickly than another.

1 Nov 2004

Many patients with sleep apnea or insomnia also have attention deficit disorder

People who have difficulty sleeping at night or staying awake during the day may suffer from more than just a sleep disorder.

25 Oct 2004

Human primitive spinal cord cells may delay symptoms and paralysis associated with Lou Gehrig's disease

Human primitive spinal cord cells delayed symptoms and paralysis by a week when implanted in the spinal cord of rats destined to develop amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, researchers from Johns Hopkins report.

24 Oct 2004

Study clearly showed the benefit of weight loss in terms of pain, function and quality of life

Over 18 months, researchers at University Hospitals of Cleveland and Case Western Reserve University studied the frequency and prevalence of musculoskeletal (MSK) complaints in obese patients before and after undergoing gastric bypass surgery.

21 Oct 2004

Genetic research offers insight into Sjögren's syndrome and the general developmental machinery of the immune system

By knocking out a single gene in mice, immunologists at Duke University Medical Center have mimicked a little-understood autoimmune disorder in humans.

21 Oct 2004

Mycophenolate mofetil is effective for managing symptoms of the most common type of lupus

Mayo Clinic investigators have found that the medication mycophenolate mofetil is effective for managing symptoms of systemic lupus erythematosus (SLE), the most common type of lupus, for patients whose SLE does not affect the kidneys.

18 Oct 2004

Researchers have discovered an effective new way to treat giant cell arteritis

Mayo Clinic researchers have discovered an effective new way to treat giant cell arteritis (GCA), a debilitating cause of headaches, fatigue, muscle pain and even blindness. The findings of this research will be presented at the American College of Rheumatology Annual Scientific Meeting.

13 Oct 2004

Health care providers need to work together to ensure that high-risk individuals get the flu shot

Dr. Eric E. Whitaker, Illinois state public health director, is encouraging health care providers to work together to ensure that high-risk individuals get the flu shot.

11 Oct 2004

Women should aim for half an hour’s gentle exercise three times a week to aid their recovery from breast cancer

Currently the standard treatment for breast cancer involves no exercise therapy. However, the initial findings from a Cancer Research UK trial has shown that exercise therapy and lifestyle counselling could hasten recovery and improve the long-term physical and mental well being of women who are recovering from breast cancer.

8 Oct 2004

Functional endoscopic sinus surgery can help people suffering from chronic fatigue caused by sinusitis

A review of published medical literature shows that functional endoscopic sinus surgery can help people suffering from chronic fatigue caused by sinusitis.

7 Oct 2004

Sedentary children at higher risk of chronic fatigue syndrome

Childhood predictors of self-reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: national birth cohort study BMJ Online First.

5 Oct 2004

As little as one standard cup of coffee a day can produce caffeine addiction

If you missed your morning coffee and now you have a headache and difficulty concentrating, you might be able to blame it on caffeine withdrawal.

29 Sep 2004

Researchers have successfully targeted an HIV protein that has eluded existing therapies

Researchers targeted Nef, a protein responsible for accelerating the development of acquired immunodeficiency syndrome, or AIDS. Nef was targeted with small molecules synthesized by the researchers – molecules that disrupted Nef’s interaction with other proteins.

26 Sep 2004